相似文献
1
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8. doi: 10.1073/pnas.1522675113. Epub 2016 Feb 8.
2
CD161 CD4 T Cells Harbor Clonally Expanded Replication-Competent HIV-1 in Antiretroviral Therapy-Suppressed Individuals.
mBio. 2019 Oct 8;10(5):e02121-19. doi: 10.1128/mBio.02121-19.
3
The role of integration and clonal expansion in HIV infection: live long and prosper.
Retrovirology. 2018 Oct 23;15(1):71. doi: 10.1186/s12977-018-0448-8.
4
Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
J Virol. 2020 Jan 31;94(4). doi: 10.1128/JVI.01519-19.
5
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections.
Viruses. 2020 Jan 25;12(2):136. doi: 10.3390/v12020136.
6
Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4). doi: 10.1073/pnas.2117630119.
7
New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
Viruses. 2021 Dec 10;13(12):2475. doi: 10.3390/v13122475.
8
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
J Infect Dis. 2021 Feb 3;223(2):225-233. doi: 10.1093/infdis/jiaa532.
9
The forces driving clonal expansion of the HIV-1 latent reservoir.
Virol J. 2020 Jan 7;17(1):4. doi: 10.1186/s12985-019-1276-8.
10
HIV-1 integration landscape during latent and active infection.
Cell. 2015 Jan 29;160(3):420-32. doi: 10.1016/j.cell.2015.01.020.
引用本文的文献
1
Clonal heterogeneity and antigenic stimulation shape persistence of the latent reservoir of HIV.
PLoS Comput Biol. 2025 Sep 15;21(9):e1013433. doi: 10.1371/journal.pcbi.1013433. eCollection 2025 Sep.
2
A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
bioRxiv. 2025 Sep 3:2025.09.02.673877. doi: 10.1101/2025.09.02.673877.
3
Proviruses in CD4 T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.
Sci Transl Med. 2025 Aug 13;17(811):eadu4643. doi: 10.1126/scitranslmed.adu4643.
4
Phylogenetics and molecular evolution to understand and curb the HIV pandemic.
Nat Rev Microbiol. 2025 Jun 30. doi: 10.1038/s41579-025-01202-w.
5
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.
J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4.
6
Prolonged non-suppressible viremia sustained by a clonally expanded, genomically defective provirus with an immune-evasive HIV protein expression profile.
bioRxiv. 2025 May 16:2025.05.16.654538. doi: 10.1101/2025.05.16.654538.
7
The intestinal interferon system and specialized enterocytes as putative drivers of HIV latency.
Front Immunol. 2025 May 14;16:1589752. doi: 10.3389/fimmu.2025.1589752. eCollection 2025.
8
Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection.
Viruses. 2025 Apr 8;17(4):547. doi: 10.3390/v17040547.
9
The Effect of SARS-CoV-2 Vaccination on HIV Viral Load in Patients Under Bictegravir/Tenofovir Alafenamide/Emtricitabine Therapy: A Retrospective Observational Study.
Healthcare (Basel). 2025 Apr 17;13(8):926. doi: 10.3390/healthcare13080926.
10
Contribution of intact viral genomes persisting in blood and tissues during ART to plasma viral rebound in SHIV-infected rhesus macaques.
iScience. 2025 Feb 11;28(3):111998. doi: 10.1016/j.isci.2025.111998. eCollection 2025 Mar 21.
本文引用的文献
1
HIV-1 integration landscape during latent and active infection.
Cell. 2015 Jan 29;160(3):420-32. doi: 10.1016/j.cell.2015.01.020.
2
The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial.
PLoS One. 2014 Dec 29;9(12):e116306. doi: 10.1371/journal.pone.0116306. eCollection 2014.
3
Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
J Allergy Clin Immunol. 2014 Jul;134(1):12-9. doi: 10.1016/j.jaci.2014.05.026. Epub 2014 Jun 26.
4
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
Clin Infect Dis. 2014 Nov 1;59(9):1312-21. doi: 10.1093/cid/ciu585. Epub 2014 Jul 29.
5
HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.
Science. 2014 Aug 1;345(6196):570-3. doi: 10.1126/science.1256304. Epub 2014 Jul 10.
6
HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.
Science. 2014 Jul 11;345(6193):179-83. doi: 10.1126/science.1254194. Epub 2014 Jun 26.
7
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7078-83. doi: 10.1073/pnas.1402873111. Epub 2014 Mar 31.
8
Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
PLoS Pathog. 2014 Mar 20;10(3):e1004010. doi: 10.1371/journal.ppat.1004010. eCollection 2014 Mar.
9
MEGA-MD: molecular evolutionary genetics analysis software with mutational diagnosis of amino acid variation.
Bioinformatics. 2014 May 1;30(9):1305-7. doi: 10.1093/bioinformatics/btu018. Epub 2014 Jan 11.
10
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.
Cell. 2013 Oct 24;155(3):540-51. doi: 10.1016/j.cell.2013.09.020.
Zotero 插件